RxDoctor Payments Data

Randall Kreulen, MD

Sports Medicine · Concord, NHNPI 1194251447

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (33.7%), grants and education — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Smith+Nephew at 58.8% of the total. Reporting peaked in 2024 at $3,949 and has fallen 98.3% since, to $66 in 2025.

$5,738in general payments, 2019–2025

Across 19 payments — averaging $302.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3K
  • Stryker$1K
  • Medical Device Business Services, Inc.$1K
  • Kairos Surgical Inc$36
  • Paladin Technology Solutions$33
  • Endo USA, Inc.$30
  • plus $24 from 1 others

What the payments were for

  • Grants$1,66729%
  • Travel & lodging$1,93634%
  • Food & beverage$4698%
  • Education$1,66729%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew3$3,374
Stryker5$1,133
Medical Device Business Services, Inc.6$1,108
Kairos Surgical Inc1$36
Paladin Technology Solutions2$33
Endo USA, Inc.1$30
Eclipse Technology Solutions Inc.1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,738 in reported general payments places this provider in the 75th percentile of 38 sports medicine providers in New Hampshire.

See all sports medicine providers in New Hampshire

Medicare billing

Part B allowed, 2024
$17,579
Medicare patients
80
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam37$48

Paid to pharmacies, not to this prescriber.

Other sports medicine in Concord

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →